Академический Документы
Профессиональный Документы
Культура Документы
JSTAR- HEALTHCARE
For the People
By the People
To the People
Caring Peoples life
Inspiring New Era in life
sciences"
12/14/2012
Confidentiality Agreement
The undersigned reader acknowledges that the information provided by _______________ in
this business plan is confidential; therefore, reader agrees not to disclose it without the express
written permission of _______________.
It is acknowledged by reader that information to be furnished in this business plan is in all
respects confidential in nature, other than information which is in the public domain through
other means and that any disclosure or use of same by reader, may cause serious harm or
damage to _______________.
Upon request, this document is to be immediately returned to _______________.
___________________
Signature
___________________
Name (typed or printed)
___________________
Date
This is a business plan. It does not imply an offering of securities.
Table of Contents
Page 1
The Company is intending to manufacture Non Alcoholic Energy Drink under the Brand name of
MARS - 180 non alcoholic energy drink. as an instant energy booster health drink and pain
killing Plasters used for fighting against pain and fractures. The said product will be procured
from overseas ( Malaysia & Germany ). This will be imported in bulk reprocessed packed in
India.
The Non Alcoholic Energy Drinks will be manufactured in INDIA an indigenous product will be
penetrated through Distributors & Channel partners all over south India.
The Plasters will be ethically promoted through Doctors ( General Practitioners, Orthopaedics
and Gynaecologists and will be distributed through pharmaceutical distributors all over
Karnataka, Tamil Nadu, Andhra Pradesh and Kerala.
The product will be exclusively imported by the Company and the Company is getting into
contract with the exporter for supply exclusively for the Company and not to others in India.
1.1 Objectives
The process of importing Energy Drink is incurring huge hidden expenses with customs, PHO &
other Government Authorities which are in turn curtailing the companys profits and to sell at
an higher cost to focus as a premium segment price tag our aim is to target on the middle
income group and the product reach should go to the mass segment at an economical
affordable price tag.
Keeping in the view the promoter has come with their own corporate identity known as M/s
JSTAR HEALTHCARE PRIVATE LIMITED having its registered office at Bangalore (hereinafter
referred to as Company). The Company also have got a strong dealers supporting in various
places of South-India to market the product.
JSTAR will indigenously manufacture Healthcare range of products such as Health drinks, Non
Alcoholic energy drinks and importing pain killing plasters, Pain Killer Oils, pain killing Ointment
Page 1
to ensure the reach of the product to mass segment and its future penetration of the products
at an economical prices tag.
JSTAR Healthcare private Limited will import these semi-raw products from overseas sourcing
from Asian and European markets.
1.2 Mission
JSTAR will indigenously manufacture Healthcare range of products such as Health drinks, Non Alcoholic
energy drinks and importing pain killing plasters, Pain Killer Oils, pain killing Ointment to ensure the reach of
the product to mass segment and its future penetration of the products at an economical prices tag.
To become a premier eye care provider by extending quality healthcare services to the next generation.
1.3 Keys to Success
There are five generally accepted keys to success in the our industry:
1. Wide range of products
2. Superior quality raw materials
3. Reliable delivery network
4. Competitive prices
5. Customer focused approach
6. No burden of Customs to Customers.
2.0 Company Summary
In leading a team from front achieving 100 % sales and heading a profit orientation in
managing Sales team motivating creating innovate Ideas in achieving the sales target.
Possessing a high level management position as National Sales Manager lead a team of 12
Regional sales Manager 3 Zonal Managers and 40 Sales representative leading from front in
achieving the organizational objectives.
Having good 10 years exposure in +\ Industry gained confidence and contacts of General
Practitioners, Orthopedicians, Pediatricians & Gynecologists.
In 2006 joined Atrimed Pharmaceuticals Pvt Limited as G M Sales & Marketing assigned for
Export Market exporting Ayurvedic products to Singapore, Malaysia, South African markets
setting up market segments to develop the sales overseas.
Established Mars Inc. as a proprietary organization in 2008 - importing, distributing of
Hospitality, Non Alcoholic Energy Drink, Confectionerys and stockiest for Dabur India Limited,
Olivia Cosmetics Pvt Limited, VLCC cosmetics in Bangalore. Strengthening the distribution
network in South India having 6 Distributing Channels in Karnataka, 4 distributing Channels in
Tamil nadu, 2 Distributing Channel in kerala and also expanding the network in Goa, Gujarat &
Maharastra for Non Alcoholic Energy Drink.
Page 2
Descriptions
Land
500
200
700
Office equipment
100
50
150
125
25
150
Building
75
50
125
800
325
1,125
300
100
400
30
15
45
Brand Ambasador
200
100
300
Marketing
100
50
150
630
265
895
1,430
590
2,020
Total A
Preliminary Expense
Advertisements
Statutory Registrations
Total B
Total A+B
Page 3
3.0 Products
The company is into 2 verticals which are as follows :
1. Energy Drinks
2. Ayurvedic Products
Health drinks
Non Alcoholic Energy Drinks
Diabetic tea
In Ayurvedic products:
Page 4
The ED has maintained a extensive track record in with all dealers and suppliers of
Pharmaceutical, Ayurvedic & Healthcare products.
ED has undergone a complete study on the customer behaviour pattern and their state of mind
for the Pharmaceutical, Ayurvedic & Healthcare products. He has done undergone study of
various types of diseases disturbing the man kind and has got extensive contacts of most of
doctors, council members of medical institutes.
Looking at the growth in the Pharmaceutical industry products and with is contacts all over the
globe has come out with some products which are used as plasters for fractures. Evaluating the
proposal it has been found the product is unique in the market and very competitive than other
traditional methods being followed in India to fight against fractures.
Page 5
ED has undergone a complete study on the customer behaviour pattern and their state of mind
for the Pharmaceutical, Ayurvedic & Healthcare products. He has done undergone study of
various types of diseases disturbing the man kind and has got extensive contacts of most of
doctors, council members of medical institutes.
Looking at the growth in the Pharmaceutical industry products and with is contacts all over the
globe has come out with some products which are used as plasters for fractures. Evaluating
the proposal it has been found the product is unique in the market and very competitive than
other traditional methods being followed in India to fight against fractures.
5.3 Sales Strategy
For energy drinks the company is going to increase the sales in stage wise basis which is in line
with the production capacity and number of shifts of manufacturing.
The sale price to the wholesale distributor will be at 65 inclusive of CST and CENVAT. The
breakup of invoice of single unit is as follows :
Product
Qty
Rate
EnergyDrink
Excise @ 12.36%
Amount
56.72
56.72
12.36%
Total
63.72
CST @ 2%
2%
1.28
Total
65
Details
Energy Drinks units
2013-14
2014-15
27,64,800
2015-16
55,29,600
82,94,400
2016-17
2017-18
1,10,59,200
1,38,24,000
Page 6
Details
Amount in Rs.
Raw Material
19.5
Labour
4.25
Power
Packing
CENVAT
Total Cost
37.75
63.73
25.98
Page 7
2013-14
2014-15
2015-16
2016-17
2017-18
Energy drink
Plaster
17,62,00,704
21,60,00,000
35,24,01,408
28,08,00,000
52,86,02,112
36,50,40,000
70,48,02,816
47,45,52,000
88,10,03,520
61,69,17,600
Turnover
63,74,21,904
1,02,50,48,808
1,44,47,92,212
1,90,62,87,066
2,42,20,58,805
4,00,00,00,000
3,50,00,00,000
3,00,00,00,000
2,50,00,00,000
2,00,00,00,000
1,50,00,00,000
1,00,00,00,000
Turnover
Plaster
Energy drink
50,00,00,000
-
Page 8
Page 9
Descriptions
Land
500
200
700
Office equipment
100
50
150
125
25
150
Building
75
50
125
800
325
1,125
300
100
400
30
15
45
Brand Ambasador
200
100
300
Marketing
100
50
150
630
265
895
1,430
590
2,020
Total A
Preliminary Expense
Advertisements
Statutory Registrations
Total B
Total A+B
The Preliminary Expenses are provided seperately as these will be amortised in 3 years as their
benifits are assumed to be for over period of 3 years.
The Advertisment cost is arrived at cost incurred for making a TV commercial and having 10
min prime airtime on popular TV channel in south India.
The Brand Ambasador is chosen to be a former Cricketor and the cost is for 3 years.
7.2 Important Assumptions
The financial plan depends on important assumptions, most of which are shown below. The key
underlying assumptions are:
1. We assume a slow-growth economy, without major recession.
2. We assume of course that there are no unforeseen changes in technology to make
products immediately obsolete.
3. The Depreciation rates are as per the Income Tax rates.
Page 10
4. The tax computed is as per the Income Tax rate of 30.90% applicable for AY 2013-14.
The same rate is taken for arriving at tax liability for all the projected years.
5. The Direct Labour charges ar as per the current market wages aplicable which is around
Rs. 7,500 per month per labour. As there are more orders the company will hire staff to
utilise the maximum possible machine capacity.
6. The inventory holding is assumed to be optimal at 30 days holding
7. The Term Loan to the company is at 16% p.a interest payable at every quarter and
there is a Board Resolution passed by the board member to the effect.
8. There is competiton and inflation expected in future year which will affect the gross
margin and net profit
9. The Receivable are taken at 2 months of Sales
10. The payable are taken at 2 months of cost of goods sold.
Term Loan
2020
Cash Net Profit after Interest and Tax adding back Depreciation :
Year 1
Year 2
Year 3
443
1086
1742
Total
3271
Page 11
2013-14
2014-15
2015-16
2016-17
2017-18
27,64,800
55,29,600
82,94,400
1,10,59,200
1,38,24,000
Sale
17,62,00,704
35,24,01,408
52,86,02,112
70,48,02,816
88,10,03,520
COS
10,43,71,200
20,87,42,400
31,31,13,600
41,74,84,800
52,18,56,000
7,18,29,504
14,36,59,008
21,54,88,512
28,73,18,016
35,91,47,520
1,00,000
24,80,000
6,00,000
35,24,014
6,00,000
1,10,000
26,04,000
6,60,000
70,48,028
6,30,000
1,21,000
27,34,200
7,26,000
1,05,72,042
6,61,500
1,33,100
28,70,910
7,98,600
1,40,96,056
6,94,575
1,46,410
30,14,456
8,78,460
1,76,20,070
7,30,000
Operating Cost
73,04,014
1,10,52,028
1,48,14,742
1,85,93,241
2,23,89,396
6,45,25,490
13,26,06,980
20,06,73,770
26,87,24,775
33,67,58,124
Margin
Cost of Manufacturing
Page 12
2013-14
2014-15
2015-16
2016-17
2017-18
90,00,000
1,17,00,000
1,52,10,000
1,97,73,000
2,57,04,900
Sale
21,60,00,000
28,08,00,000
36,50,40,000
47,45,52,000
61,69,17,600
COS
14,08,50,000
18,31,05,000
23,80,36,500
30,94,47,450
40,22,81,685
7,51,50,000
9,76,95,000
12,70,03,500
16,51,04,550
21,46,35,915
50,000
74,40,000
6,00,000
43,20,000
6,00,000
55,000
78,12,000
6,60,000
56,16,000
6,30,000
60,500
82,02,600
7,26,000
73,00,800
6,61,500
66,550
94,32,990
8,34,900
83,95,920
7,60,725
73,205
1,08,47,939
9,60,135
96,55,308
8,74,834
Operating Cost
1,30,10,000
1,47,73,000
1,69,51,400
1,94,91,085
2,24,11,420
6,21,40,000
8,29,22,000
11,00,52,100
14,56,13,465
19,22,24,495
Margin
Cost of Manufacturing
Communication
Manpower
Consultancy & Regulatories
Transportation
Factory Maintenance
2013-14
Total Profit
6,45,25,490
6,21,40,000
2014-15
2015-16
2016-17
2017-18
13,26,06,980
20,06,73,770
26,87,24,775
33,67,58,124
8,29,22,000
11,00,52,100
14,56,13,465
19,22,24,495
12,66,65,490
21,55,28,980
31,07,25,870
41,43,38,240
52,89,82,619
Depreciation
Statutor registration & Compliances
Marketing
Interest
50,00,000
45,00,000
2,83,33,333
3,20,00,000
43,87,500
2,83,33,333
3,20,00,000
38,53,125
2,83,33,333
3,20,00,000
33,86,531
2,83,33,333
29,78,789
2,83,33,333
Total A
6,98,33,333
6,47,20,833
6,41,86,458
3,17,19,864
3,13,12,122
5,68,32,157
15,08,08,147
24,65,39,412
38,26,18,375
49,76,70,497
Tax
1,75,61,136
4,65,99,717
7,61,80,678
11,82,29,078
15,37,80,184
3,92,71,021
10,42,08,430
17,03,58,734
26,43,89,297
34,38,90,313
Page 13
Page 14
2013-14
2014-15
2015-16
2016-17
2017-18
3,92,71,021
10,42,08,430
17,03,58,734
26,43,89,297
34,38,90,313
50,00,000
43,87,500
38,53,125
33,86,531
29,78,789
4,42,71,021
10,85,95,930
17,42,11,859
26,77,75,829
34,68,69,102
(10,00,000)
(7,71,09,836)
(4,08,70,200)
2,04,35,100
16,92,835
1,75,61,136
(2,84,23,732)
(2,44,37,700)
1,22,18,850
4,59,251
2,90,38,581
(4,34,06,784)
(2,65,50,450)
1,32,75,225
4,95,093
2,95,80,961
(20,00,00,000)
(4,76,18,784)
(2,92,97,025)
1,46,48,513
5,26,515
4,20,48,400
(5,30,94,384)
(3,28,67,573)
1,64,33,786
5,59,707
3,55,51,106
(7,92,90,965)
(1,11,44,750)
(2,66,05,955)
(21,96,92,381)
(3,34,17,357)
9,74,51,180
14,76,05,904
4,80,83,448
31,34,51,745
2,83,33,333
2,83,33,333
(20,20,00,000)
-
Net Profit
Depreciation
Cash Profit
Changes in Working Capital
78,13,390
-
78,13,390
12,57,84,513
(2,60,60,763)
4,80,83,448
31,34,51,745
78,13,390
13,35,97,902
10,75,37,139
15,56,20,587
13,35,97,902
10,75,37,139
15,56,20,587
46,90,72,332
Page 15
30,00,00,000
20,00,00,000
10,00,00,000
-
2013-14
2014-15
2015-16
2016-17
2017-18
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
3,92,71,021
14,34,79,451
31,38,38,185
57,82,27,482
92,21,17,795
20,20,00,000
20,20,00,000
1,75,61,136
16,92,835
2,04,35,100
4,65,99,717
21,52,086
3,26,53,950
7,61,80,678
26,47,179
4,59,29,175
11,82,29,078
31,73,694
6,05,77,688
15,37,80,184
37,33,401
7,70,11,474
29,09,60,091
43,68,85,203
44,85,95,216
77,02,07,941
1,16,66,42,854
Total
Assets
Cash on hand
Cash at Bank
Fixed Assets
Tangible
Non- tangable
Loans and Advances
Trade Debtors
Stock in hand
5,00,000
73,13,390
15,00,000
13,20,97,902
15,00,000
10,60,37,139
15,00,000
15,41,20,587
15,00,000
46,75,72,332
10,75,00,000
5,66,66,666
10,00,000
7,71,09,836
4,08,70,200
10,31,12,500
2,83,33,333
10,00,000
10,55,33,568
6,53,07,900
9,92,59,375
10,00,000
14,89,40,352
9,18,58,350
9,58,72,844
20,10,00,000
19,65,59,136
12,11,55,375
9,28,94,055
20,10,00,000
24,96,53,520
15,40,22,948
Total
29,09,60,091
43,68,85,203
44,85,95,216
77,02,07,941
1,16,66,42,854
Page 16
2013-14
Projection
2014-15
Projection
2015-16
Projection
2016-17
Projection
Net Sales
39,22,00,704
63,32,01,408
89,36,42,112
1,17,93,54,816
P B ILD T
9,38,32,157
18,71,95,647
28,23,92,537
38,60,04,907
PBT
5,68,32,157
15,08,08,147
24,65,39,412
38,26,18,375
P AT
3,92,71,021
10,42,08,430
17,03,58,734
26,43,89,297
4,42,71,021
10,85,95,930
17,42,11,859
26,77,75,829
23.92%
29.56%
31.60%
32.73%
10.01%
16.46%
19.06%
22.42%
Dividend/PAT (%)
Gross Block
11,25,00,000
10,75,00,000
10,31,12,500
9,92,59,375
10
Net Block
10,75,00,000
10,31,12,500
9,92,59,375
9,58,72,844
11
Paid up Capital
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
12
12,51,46,118
24,15,670
24,82,283
13
Group Invetsments
14
Adjusted T N W
15
(73,95,645)
-
(73,95,645)
12,51,46,118
LTD /T NW
(27.31)
1.61
16
DFS/TNW
17
TO L/TNW
-32.68
18
Current Assets
19
24,15,670
2.26
24,82,283
51.64
73.31
12,67,93,425
30,54,39,370
34,93,35,841
67,43,35,098
Current Liabilities
3,96,89,071
8,14,05,753
12,47,57,032
18,19,80,459
20
8,71,04,355
22,40,33,618
22,45,78,810
49,23,54,638
21
Current Ratio
3.19
3.75
2.80
3.71
45.65%
55.88%
86.01%
65.05%
2.93
5.85
8.82
#DIV/0!
5.85
8.82
#DIV/0!
Other Indicators
22
R O C E (%)
23
24
DSCR
2014-15
2015-16
13,69,29,263
20,25,45,192
20,20,00,000
13,69,29,263
5,45,192
140.90%
14.37%
2016-17
26,77,75,829
26,77,75,829
93.03%
Page 17
1. SOURCES
a. Net Profit
b. Depreciation
c. Increase in Capital
d. Increase in Term Liabilities
(including Public Deposits)
e. Decrease in
i.
Fixed Assets
ii. Other non-current Assets
f.
Others
g. TOTAL
2. USES
a. Net loss
b. Decrease in Term Liabilities
(including Public Deposits)
c. Increase in
i.
Fixed Assets
ii. Other non-current Assets
d. Dividend Payments
e. Others
f.
TOTAL
3. Long Term Surplus (+) / Deficit (-) [1-2]
4. Increase/decrease in current assets
* (as per details given below)
5. Increase/decrease in current liabilities
other than bank borrowings
6. Increase/decrease in working capital gap
7. Net Surplus / Deficit (-) [3-6]
8. Increase/decrease in bank borrowings
9. Increase/decrease in NET SALES
Projections
Projections
Projections
Projections
2014-15
2015-16
2016-17
2017-18
10,42,08,430
(6,12,500)
-
50,00,000
2,83,33,333
13,69,29,263
43,87,500
2,83,33,333
20,25,45,192
38,53,125
33,86,531
0
26,77,75,829
34,68,69,102
20,20,00,000
0
0
20,20,00,000
13,69,29,263
5,45,192
26,77,75,829
34,68,69,102
17,86,45,945
4,38,96,471
32,49,99,257
39,94,13,702
4,33,51,279
5,72,23,428
5,45,192 26,77,75,829
(0)
26,04,40,704 28,57,12,704
5,25,44,600
34,68,69,102
0
31,85,66,304
4,17,16,682
13,69,29,263
24,10,00,704
* Break up of item-4
i. Increase/decrease in Raw Materials
2,44,37,700
ii. Increase/decrease in Stocks-in-Process
iii. Increase/decrease in Finished Goods
iv. Increase/decrease in Receivables
a) Domestic
2,66,171
b) Export
v. Increase/decrease in Stores & Spares
vi. Increase/decrease in other current assets
15,39,42,074
TOTAL 17,86,45,945
2,65,50,450
-
2,92,97,025
-
3,28,67,573
-
6,98,745
1,66,47,276
4,38,96,471
5,00,000
29,52,02,232
32,49,99,257
5,23,875
36,60,22,254
39,94,13,702
Page 18
Appendix
Page 1